BioLineRx Ltd.
BLRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001498403
No open-market purchases or sales by BioLineRx Ltd. insiders were filed in the last 90 days; 14 institutions reported holding it in 13F filings for Q2 2026, worth $206.7K in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding BioLineRx Ltd. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 30 | 30 | 0 |
| Shares | 1.42M | 2.43M | +1.01M (+70.8%) |
| Value | $4.01M | $6.69M | +$2.67M (+66.6%) |
New holders (6)
Institutions that held BioLineRx Ltd. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| ARK Investment Management LLCSuperinvestorARK Invest | 1,073,913 | $2.95M | 0.01% |
| Susquehanna International Group, LLP | 77,680 | $212.0K | 0.00% |
| PVG Asset Management Corp | 76,510 | $210.4K | 0.63% |
| Envestnet Asset Management Inc | 42,928 | $118.0K | 0.00% |
| Schonfeld Strategic Advisors LLC | 12,100 | $33.0K | 0.00% |
| Group One Trading, L.P. | 4,386 | $12.0K | 0.00% |
Sold out (6)
Institutions that held BioLineRx Ltd. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Virtu Financial LLC | 16,578 | $47.0K |
| Millennium Management LLC | 14,922 | $42.0K |
| UBS Group AG | 6,296 | $18.0K |
| Spire Wealth Management | 3,000 | $8.00K |
| Concord Wealth Partners | 200 | $1.00K |
| FMR LLC | 1 | $0 |